PHARMACY-BIOLOGICAL PRODUCTS Senate SponsorsSen. Antonio Muņoz 1/10/2017SenateSession Sine Die 225 ILCS 85/19.5 newAmends the Pharmacy Practice Act. Provides that a pharmacist may substitute a prescription biological product for a prescribed biological product only if specified criteria are met. Requires that, within a reasonable time following the dispensing of a biological product, the dispensing pharmacist or the pharmacist's designee shall communicate to the prescriber the specific product provided to the patient, including the name of the product and the manufacturer. Requires the pharmacy to retain a record of the biological product dispensed for a period of 5 years. Requires the State Board of Pharmacy to maintain a link on the Department's Internet web site to the current list of all biological products determined by the United States Food and Drug Administration to be interchangeable with a specific biological product. Effective immediately. 2/20/2015SenateFiled with Secretary by Sen. Antonio Muņoz 2/20/2015SenateFirst Reading 2/20/2015SenateReferred to Assignments 3/5/2015SenateAssigned to Executive 3/19/2015SenateSenate Committee Amendment No. 1 Filed with Secretary by Sen. Antonio Muņoz 3/19/2015SenateSenate Committee Amendment No. 1 Referred to Assignments 3/24/2015SenateSenate Committee Amendment No. 1 Assignments Refers to Executive 3/26/2015SenatePostponed - Executive 3/26/2015SenateSenate Committee Amendment No. 1 Postponed - Executive 3/27/2015SenateRule 2-10 Committee Deadline Established As April 24, 2015 4/24/2015SenateRule 2-10 Committee/3rd Reading Deadline Established As May 15, 2015 5/15/2015SenateRule 2-10 Committee/3rd Reading Deadline Established As May 31, 2015 10/10/2015SenatePursuant to Senate Rule 3-9(b) / Referred to Assignments 10/10/2015SenateSenate Committee Amendment No. 1 Pursuant to Senate Rule 3-9(b) / Referred to Assignments 1/10/2017SenateSession Sine Die